{"nct_id":"NCT02465515","title":"Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","status_verified_date":"2019-02","start_date":"2015-07-01","start_date_type":"ACTUAL","primary_completion_date":"2018-02-20","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-14","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}